Path: utzoo!utgpu!news-server.csri.toronto.edu!cs.utexas.edu!usc!ucla-cs!usenet
From: IQTI400%INDYCMS.BITNET@mvs.oac.ucla.edu (MacPhil)
Newsgroups: sci.med.aids
Subject: Re: (3246) New England Journal of Medicine
Message-ID: <1991Jun13.030454.13949@cs.ucla.edu>
Date: 12 Jun 91 19:11:24 GMT
Sender: usenet@cs.ucla.edu (Mr. News Himself)
Organization: UCLA, Computer Science Department
Lines: 29
Approved: phil@wubios.wustl.edu
Note: non-commercial reproduction.
Nntp-Posting-Host: squid.cs.ucla.edu
Archive-Number: 3247

On Wed, 12 Jun 91 12:02:21 pdt Support Account for SCI.MED.AIDS said:
>Recently I was told this by a friend of mine (thanx, Mark):
>
>> A report in today's New England Journal of Medicine describes researchers
>>successfully reducing the severity of AIDS symptoms with a genetically-
>>engineered vaccine. I heard this on the radio.
>
>Hello, if anyone knows the resources (date/number/etc) of the
>New England Journal of Medicine so I update my files, I'd greatly
>appreciate it.
>
>I would also like to hear some commentary on how the vaccine works.
>

It will be in the _New England Journal of Medicine_ to be dated tomorrow,
Thursday, June 13.

I have heard via other reports that it is a virus made from the outer
coating and that it does not not necessarily reduce the symptoms but
halts the advance of the disease and seems to spur an immune
system reaction.  The results are still preliminary as there are
no short-term side-effects, etc. but it will take time to see if
there are any long-term effects.

The research was conducted at Walter Reed on thirty volunteers.

----------------------------------------------------------------
       MacPhil                       iqti400@indycms.bitnet
1-800-972-8744 x40836              iqti400@indycms.iupui.edu